hrp0089rfc13.1 | Pituitary, Neuroendocrinology and Puberty 2 | ESPE2018
Hippolyte Helene
, De Carli Emilie
, Pellier Isabelle
, Delion Matthieu
, Rakotonjanahary Josue
, Rialland Xavier
, Coutant Regis
For the brain tumor committee of SFCE (Société Française des Cancers de lÂ’Enfant).Objective: Therapeutic approach favors chemotherapy as the first-line-treatment in progressing OPG. There are few data on long term endocrine outcomes of aggressive OPG treated by upfront chemotherapy. Our main objective was to describe the long-term endocrine sequelae in these patients and to identify potential early predictors of the endocrine involvem...